Mefoxin and Scan bone marrow abnormal - a phase IV clinical study of FDA data

Summary:

Scan bone marrow abnormal is reported as a side effect among people who take Mefoxin (cefoxitin sodium), especially for people who are female, 50-59 old, also take Evista, and have Osteoporosis.

The phase IV clinical study analyzes which people have Scan bone marrow abnormal when taking Mefoxin. It is created by eHealthMe based on reports of 276 people who have side effects when taking Mefoxin from the FDA, and is updated regularly.

What is Mefoxin?

Mefoxin has active ingredients of cefoxitin sodium. eHealthMe is studying from 280 Mefoxin users. Check the latest studies of Mefoxin.

What is Scan bone marrow abnormal?

Scan bone marrow abnormal is found to be associated with 96 drugs and 34 conditions by eHealthMe. Check the latest studies of Scan bone marrow abnormal.

On Aug, 06, 2026

276 people reported to have side effects when taking Mefoxin.
Among them, 17 people (6.16%) have Scan bone marrow abnormal.

Could Mefoxin cause Scan bone marrow abnormal?

Among these 17 people:

What is the gender of people who have Scan bone marrow abnormal when taking Mefoxin? *

female: 100 %
male: 0.0 %

What is the age of people who have Scan bone marrow abnormal when taking Mefoxin? *

What are other drugs people take besides Mefoxin? *

What are other side effects people have besides Scan bone marrow abnormal? *

Wound Infection Staphylococcal: 17 people, 100.00%
Humerus Fracture (injury to the upper arm bone): 17 people, 100.00%
Foot Fracture: 17 people, 100.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 17 people, 100.00%
Generalised Oedema (swelling all over the body): 17 people, 100.00%
Gingival Infection (gum infection): 17 people, 100.00%
Gingival Pain (gum pain): 17 people, 100.00%
Gingivitis (inflammation of gums): 17 people, 100.00%
Gums - Swollen: 17 people, 100.00%
Haemangioma (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs): 17 people, 100.00%

What are the existing conditions these people have? *

Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 17 people, 100.00%
Osteoporosis (bones weak and more likely to break): 17 people, 100.00%
Thrombocytopenia (decrease of platelets in blood): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Mefoxin and have Scan bone marrow abnormal?

- Check whether Scan bone marrow abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mefoxin:

Mefoxin (280 reports)

Browse all side effects of Mefoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Scan bone marrow abnormal:

Scan bone marrow abnormal (96 drugs)

Browse all the conditions that are associated with Scan bone marrow abnormal:

Scan bone marrow abnormal (34 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefoxitin sodium (the active ingredients of Mefoxin) and Mefoxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.